These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 11578847)

  • 1. Development of lysosomal storage in mice with targeted disruption of the beta-galactosidase gene: a model of human G(M1)-gangliosidosis.
    Itoh M; Matsuda J; Suzuki O; Ogura A; Oshima A; Tai T; Suzuki Y; Takashima S
    Brain Dev; 2001 Oct; 23(6):379-84. PubMed ID: 11578847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GM1-gangliosidosis in American black bears: clinical, pathological, biochemical and molecular genetic characterization.
    Muthupalani S; Torres PA; Wang BC; Zeng BJ; Eaton S; Erdelyi I; Ducore R; Maganti R; Keating J; Perry BJ; Tseng FS; Waliszewski N; Pokras M; Causey R; Seger R; March P; Tidwell A; Pfannl R; Seyfried T; Kolodny EH; Alroy J
    Mol Genet Metab; 2014 Apr; 111(4):513-21. PubMed ID: 24581871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-galactosidase-deficient mouse as an animal model for GM1-gangliosidosis.
    Matsuda J; Suzuki O; Oshima A; Ogura A; Noguchi Y; Yamamoto Y; Asano T; Takimoto K; Sukegawa K; Suzuki Y; Naiki M
    Glycoconj J; 1997 Sep; 14(6):729-36. PubMed ID: 9337086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic AAV9 gene transfer in adult GM1 gangliosidosis mice reduces lysosomal storage in CNS and extends lifespan.
    Weismann CM; Ferreira J; Keeler AM; Su Q; Qui L; Shaffer SA; Xu Z; Gao G; Sena-Esteves M
    Hum Mol Genet; 2015 Aug; 24(15):4353-64. PubMed ID: 25964428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive behavioral and biochemical outcomes of novel murine models of GM1-gangliosidosis and Morquio syndrome type B.
    Przybilla MJ; Ou L; Tăbăran AF; Jiang X; Sidhu R; Kell PJ; Ory DS; O'Sullivan MG; Whitley CB
    Mol Genet Metab; 2019 Feb; 126(2):139-150. PubMed ID: 30528226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lysosomal accumulation of Trk protein in brain of GM₁ -gangliosidosis mouse and its restoration by chemical chaperone.
    Takamura A; Higaki K; Ninomiya H; Takai T; Matsuda J; Iida M; Ohno K; Suzuki Y; Nanba E
    J Neurochem; 2011 Aug; 118(3):399-406. PubMed ID: 21574998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular consequences of the pathogenic mutation in feline GM1 gangliosidosis.
    Martin DR; Rigat BA; Foureman P; Varadarajan GS; Hwang M; Krum BK; Smith BF; Callahan JW; Mahuran DJ; Baker HJ
    Mol Genet Metab; 2008 Jun; 94(2):212-21. PubMed ID: 18353697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insights into post-translational processing of beta-galactosidase in an animal model resembling late infantile human G-gangliosidosis.
    Kreutzer R; Kreutzer M; Pröpsting MJ; Sewell AC; Leeb T; Naim HY; Baumgärtner W
    J Cell Mol Med; 2008; 12(5A):1661-71. PubMed ID: 18088383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complete correction of enzymatic deficiency and neurochemistry in the GM1-gangliosidosis mouse brain by neonatal adeno-associated virus-mediated gene delivery.
    Broekman ML; Baek RC; Comer LA; Fernandez JL; Seyfried TN; Sena-Esteves M
    Mol Ther; 2007 Jan; 15(1):30-7. PubMed ID: 17164772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemokine-induced recruitment of genetically modified bone marrow cells into the CNS of GM1-gangliosidosis mice corrects neuronal pathology.
    Sano R; Tessitore A; Ingrassia A; d'Azzo A
    Blood; 2005 Oct; 106(7):2259-68. PubMed ID: 15941905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generalized CNS disease and massive GM1-ganglioside accumulation in mice defective in lysosomal acid beta-galactosidase.
    Hahn CN; del Pilar Martin M; Schröder M; Vanier MT; Hara Y; Suzuki K; Suzuki K; d'Azzo A
    Hum Mol Genet; 1997 Feb; 6(2):205-11. PubMed ID: 9063740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemical chaperone therapy for brain pathology in G(M1)-gangliosidosis.
    Matsuda J; Suzuki O; Oshima A; Yamamoto Y; Noguchi A; Takimoto K; Itoh M; Matsuzaki Y; Yasuda Y; Ogawa S; Sakata Y; Nanba E; Higaki K; Ogawa Y; Tominaga L; Ohno K; Iwasaki H; Watanabe H; Brady RO; Suzuki Y
    Proc Natl Acad Sci U S A; 2003 Dec; 100(26):15912-7. PubMed ID: 14676316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous delivery of adeno-associated viral gene therapy in feline GM1 gangliosidosis.
    Gross AL; Gray-Edwards HL; Bebout CN; Ta NL; Nielsen K; Brunson BL; Lopez Mercado KR; Osterhoudt DE; Batista AR; Maitland S; Seyfried TN; Sena-Esteves M; Martin DR
    Brain; 2022 Apr; 145(2):655-669. PubMed ID: 34410345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A GM1 gangliosidosis mutant mouse model exhibits activated microglia and disturbed autophagy.
    Liu S; Feng Y; Huang Y; Jiang X; Tang C; Tang F; Zeng C; Liu L
    Exp Biol Med (Maywood); 2021 Jun; 246(11):1330-1341. PubMed ID: 33583210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultrastructural lesions of ovine GM1 gangliosidosis.
    Murnane RD; Ahern-Rindell AJ; Prieur DJ
    Mod Pathol; 1991 Nov; 4(6):755-62. PubMed ID: 1788267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A beta-galactosidase gene mutation identified in both Morquio B disease and infantile GM1 gangliosidosis.
    Suzuki Y; Oshima A
    Hum Genet; 1993 May; 91(4):407. PubMed ID: 8500799
    [No Abstract]   [Full Text] [Related]  

  • 17. Lysosomal multienzyme complex: pros and cons of working together.
    Bonten EJ; Annunziata I; d'Azzo A
    Cell Mol Life Sci; 2014 Jun; 71(11):2017-32. PubMed ID: 24337808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AAV9-coGLB1 Improves Lysosomal Storage and Rescues Central Nervous System Inflammation in a Mutant Mouse Model of GM1 Gangliosidosis.
    Liu S; Ma W; Feng Y; Zhang Y; Jia X; Tang C; Tang F; Wu X; Huang Y
    Curr Gene Ther; 2022; 22(4):352-365. PubMed ID: 35249485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enzyme replacement for GM1-gangliosidosis: Uptake, lysosomal activation, and cellular disease correction using a novel β-galactosidase:RTB lectin fusion.
    Condori J; Acosta W; Ayala J; Katta V; Flory A; Martin R; Radin J; Cramer CL; Radin DN
    Mol Genet Metab; 2016 Feb; 117(2):199-209. PubMed ID: 26766614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical Enzyme Replacement Therapy with a Recombinant β-Galactosidase-Lectin Fusion for CNS Delivery and Treatment of GM1-Gangliosidosis.
    Weesner JA; Annunziata I; Yang T; Acosta W; Gomero E; Hu H; van de Vlekkert D; Ayala J; Qiu X; Fremuth LE; Radin DN; Cramer CL; d'Azzo A
    Cells; 2022 Aug; 11(16):. PubMed ID: 36010656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.